(Q34212373)

31 July 2017

1 reference

title

Coagulation dysfunction in sepsis and multiple organ system failure (English)

1 reference

31 July 2017

0 references

Marianne Nimah

1

1 reference

PubMed ID

12848314

31 July 2017

Richard J Brilli

series ordinal

2

1 reference

31 July 2017

1 July 2003

1 reference

31 July 2017

Critical Care Clinics

1 reference

31 July 2017

19

1 reference

31 July 2017

3

1 reference

31 July 2017

441-458

1 reference

Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

1 reference

7 January 2021

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

1 reference

7 January 2021

Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Time course of hemostatic abnormalities in sepsis and its relation to outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Disseminated Intravascular Coagulation and Sustained Systemic Inflammatory Response Syndrome Predict Organ Dysfunctions After Trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Cytokines and anticytokines in the pathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Neutrophil and endothelial cell interactions in sepsis. The role of adhesion molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Pathophysiology of disseminated intravascular coagulation in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Gram-positive organisms and sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Disseminated intravascular coagulation: pathophysiological mechanisms and manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Endothelium: interface between coagulation and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Alterations in coagulation and fibrinolysis during sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Cell biology of tissue factor, the principal initiator of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Complement-mediated regulation of tissue factor activity in endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Therapeutic rationale for antithrombin III in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Coagulation inhibitor replacement in sepsis is a potentially useful clinical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Hemostatic study before onset of disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Antithrombin III and sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Evidence that C4b-binding protein is an acute phase protein

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Activation of the protein C pathway in acute sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

The protein C pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Tissue factor pathway inhibitor activity in severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Evolving role of tissue factor and its pathway inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Novel approaches to the management of disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Pathophysiology and treatment of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Fibrinolytic response to tumor necrosis factor in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Septic shock: clinical, physiological, and pathological survey of 244 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Multiple organ dysfunction: baseline and serial component scores

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Changing pattern of organ dysfunction in early human sepsis is related to mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis. Possible indication of the degree of endothelial cell activation?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Protein C levels as a prognostic indicator of outcome in sepsis and related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Purpura fulminans in meningococcemia: association with acquired deficiencies of proteins C and S.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Increased circulating thrombomodulin in children with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Thrombomodulin in intensive care patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Clinical trial results with antithrombin III in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Substitution of antithrombin III in shock and DIC: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Effect of antithrombin concentrate on haemostatic variables in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Use of antithrombin III in critical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Treatment of purpura fulminans in meningococcemia with protein C concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Protein C in the treatment of coagulopathy in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Cofactors V and VIII after endotoxin administration to human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900008-3

7 January 2021

10.1016/S0749-0704(03)00008-3

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12848314